<p>Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’</p><p>The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday.</p><p>It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, <a href="https://www.linkedin.com/pulse/missed-opportunity-guinea-bissaus-children-why-trial-frederik-wttde/">wrote</a> on LinkedIn, adding, “we were not given the necessary governmental approval.”</p> <a href="https://www.theguardian.com/world/2026/oct/21/us-vaccine-trial-african-newborns-hepatitis-b">Continue reading...</a>
World
Controversial US-backed vaccine trial in African newborns halted
<p>Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’</p><p>The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday.</p><p>It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, <a href="https://www.linkedin.com/pulse/missed-opportunity-guinea-bissaus-children-why-trial-frederik-wttde/">wrote</a> on LinkedIn, adding, “we were not given the necessary governmental approval.”</p> <a href="https://www.theguardian.com/world/2026/oct/21/us-vaccine-trial-african-newborns-hepatitis-b">Continue reading...</a>